Module-level recombination drives DBLMSP polymorphism and functional conservation in Plasmodium falciparum. [PDF]
Duan YW +6 more
europepmc +1 more source
Cross-kingdom microbial interactions in the gut during inflammatory bowel disease. [PDF]
Li L +20 more
europepmc +1 more source
Identification of highly cross-reactive immunogens in Eimeria tenella sporozoites. [PDF]
Chen W +6 more
europepmc +1 more source
Molecular characterisation of Toxoplasma gondii Mre11 reveals unique structural features and potential as a therapeutic target. [PDF]
Ruiz DM +3 more
europepmc +1 more source
Insights into the lifecycle of Cryptosporidium and compounds targeting developmental stages. [PDF]
Reynolds Z, Vinayak S.
europepmc +1 more source
MicroRNAs orchestrating host and vector-borne protozoan interactions: bridging immune modulation and cross-species communication. [PDF]
Li J, Zhu F, Zhang J.
europepmc +1 more source
Computational vaccine development against protozoa. [PDF]
Hashim O, Dimier-Poisson I.
europepmc +1 more source
A Multivalent Peptide Vaccine Against Malaria, Targeting Plasmodium Circumsporozoite Protein and Mosquito AgTRIO. [PDF]
Chuang YM +3 more
europepmc +1 more source
Production of recombinant proteins from protozoan parasites [PDF]
Although the past decade has witnessed sequencing from an increasing number of parasites, modern high-throughput DNA sequencing technologies have the potential to generate complete genome sequences at even higher rates. Along with the discovery of genes that might constitute potential targets for chemotherapy or vaccination, the need for novel protein ...
Gerardo Vasta
exaly +3 more sources
Related searches:
Using Protozoan Surface Proteins for Effective Oral Vaccination
Trends in Parasitology, 2020The Global Vaccine Action Plan of the World Health Organization (WHO) calls for nonsyringe delivery mechanisms, thermostable vaccines, and new bioprocessing technologies as priority research areas. Here we discuss the use of protozoan surface proteins to develop a safe, stable, and efficient versatile oral vaccine platform.
Lucia Lara Rupil
exaly +3 more sources

